Did any adverse reactions happen during this study?
Group 1 Group 2
Treatment A Treatment B Treatment C Treatment D
(out of 40 (out of 39 (out of 39 (out of 39
participants) participants) participants) participants)
How many
participants
30.0% (12) 20.5% (8) 23.1% (9) 25.6% (10)
had adverse
reactions?
How many
participants had
0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
serious adverse
reactions?
How many
participants
stopped taking
2.5% (1) 0.0% (0) 0.0% (0) 0.0% (0)
study treatment
due to adverse
reactions?
What serious adverse reactions happened during this study?
There were no serious adverse reactions during the study.
There were 2.5% of participants who stopped taking study treatment due to an
adverse reaction of liver damage. This was 1 out of 40 participants in Group 1.
This participant took Treatment A but did not go on to take Treatment B.
9 | Clinical Study Results